Triple
T4492403
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Alnylam Pharmaceuticals |
E100609
|
entity |
| Predicate | foundedBy |
P104
|
FINISHED |
| Object |
Thomas Tuschl
Thomas Tuschl is a German biochemist and pioneering RNA interference researcher whose work helped lay the scientific foundation for RNA-based therapeutics.
|
E849217
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69bd43cdf15081909a4fa2585ff63b3e |
elicitation | completed |
| NER | batch_69bd556f99b48190ae60506a35b43c29 |
ner | completed |
| NED1 | batch_69d5f2bfdc5881909689a8b24d605458 |
ned_source_triple | completed |
| NED2 | batch_69d5f47d850c8190afebd2c769364e0f |
ned_description | completed |
| NEDg | batch_69d5f42e2d44819089d524c5757ee141 |
nedg | completed |
Created at: March 20, 2026, 12:59 p.m.